The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Open accessAbstract
Mutations affecting spliceosomal proteins are the most common mutations in patients with myelodysplastic syndromes (MDS), but their role in MDS pathogenesis has not been delineated. Here we report that mutations affecting the splicing factor SRSF2 directly impair hematopoietic differentiation in vivo, which is not due to SRSF2 loss of function. By contrast, SRSF2 mutations alter SRSF2's normal sequence-specific RNA binding activity, thereby altering the recognition of specific exonic splicing enhancer motifs to drive recurrent mis-splicing of key hematopoietic regulators. This includes SRSF2 mutation-dependent splicing of EZH2, which triggers nonsense-mediated decay, which, in turn, results in impaired hematopoietic differentiation. These data provide a mechanistic link between a mutant spliceosomal protein, alterations in the splicing of key regulators, and impaired hematopoiesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HSCs from mice mutant for these genes, Sf3b1 56, Srsf2 57, and U2af1 58, have a competitive disadvantage in vivo, unlike the clonal expansion observed in humans with these mutations.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes
Siepel, A., Bejerano, G., Pedersen, J. S., Hinrichs, A. S., Hou, M., Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L. W., Richards, S., et al. (2005) · Genome Research · doi:10.1101/gr.3715005 · Cited by 3,971 · cited 2×
“(B) IntegrativeGenomics Viewer (IGV)/Sashimi plot illustrating theEZH2 cassette e patient numbers listed in the Sashimi plot correspond to the numbers in Table S1 as estimated by phastCons (Siepel et al., 2005), across 30 vertebrate species is (C) Bar plot describing the percentage of EZH2 transcripts harboring a spec…”
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Self-citationSomatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C. L., Stevenson, K. E., Werner, L. L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,103
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez‐Trillos, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 1,022
Mutations and prognosis in primary myelofibrosis
Vannucchi, A. M., Lasho, T. L., Guglielmelli, P., Biamonte, F., Pardanani, A. D., Pereira, A., Finke, C. M., Score, J., Gangat, N., Mannarelli, C., et al. (2013) · Leukemia · doi:10.1038/leu.2013.119 · Cited by 793
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Nikoloski, G., Langemeijer, S. M. C., Kuiper, R. P., Knops, R., Massop, M., Tönnissen, E., van der Heijden, A., Scheele, T. N., Vandenberghe, P., de Witte, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.620 · Cited by 777
Bayesian hypothesis testing for psychologists: A tutorial on the Savage–Dickey method
Wagenmakers, E.-J., Lodewyckx, T., Kuriyal, H., & Grasman, R. (2010) · Cognitive Psychology · doi:10.1016/j.cogpsych.2009.12.001 · Cited by 740
Oguro, H., Ding, L., & Morrison, S. J. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.014 · Cited by 692
Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements
Lareau, L. F., Inada, M., Green, R. E., Wengrod, J., & Brenner, S. E. (2007) · Nature · doi:10.1038/nature05676 · Cited by 685
Pronk, C. J. H., Rossi, D. J., Månsson, R., Attema, J. L., Norddahl, G. L., Chan, C. K. F., Sigvardsson, M., Weissman, I. L., & Bryder, D. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.005 · Cited by 671
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Graubert, T. A., Shen, D., Ding, L., Okeyo-Owuor, T., Shirai, C. L., Shao, J., Krysiak, K., Harris, C. C., Koboldt, D. C., Larson, D. E., et al. (2011) · Nature Genetics · doi:10.1038/ng.1031 · Cited by 604
Ni, J. Z., Grate, L. R., Donohue, J. P., Preston, C. G., Nobida, N., O’Brien, G. S., Shiue, L., Clark, T. A., Blume, J. E., & Ares, M. (2007) · Genes & Development · doi:10.1101/gad.1525507 · Cited by 551
Bejar, R. L., Stevenson, K. E., Caughey, B. A., Abdel-Wahab, O. I., Steensma, D. P., Galili, N., Raza, A., Kantarjian, H. M., Levine, R. L., Neuberg, D. S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7379 · Cited by 450
Self-citationLandscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes
Nagata, Y., Grossmann, V., Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Shiozawa, Y., Kon, A., Alpermann, T., Yoshida, K., et al. (2013) · Blood · doi:10.1182/blood.v122.21.521.521 · Cited by 430
U2AF1 mutations alter splice site recognition in hematological malignanciesPreprint
Ilagan, J. O., Ramakrishnan, A., Hayes, B. J., Murphy, M. E., Zebari, A. S., Bradley, P. H., & Bradley, R. K. (2014) · Genome Research · doi:10.1101/gr.181016.114 · Cited by 293
Self-citationExonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions
Liu, H., Chew, S. L., Cartegni, L., Zhang, M. Q., & Krainer, A. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1063-1071.2000 · Cited by 244
Zhang, S.-J., Rampal, R. K., Manshouri, T., Patel, J. L., Mensah, N. Y., Kayserian, A., Hricik, T., Heguy, A., Hedvat, C. V., Gönen, M., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390252 · Cited by 229
Self-citationArginine/Serine-Rich Domains of SR Proteins Can Function as Activators of Pre-mRNA Splicing
Graveley, B. R., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80076-3 · Cited by 217
Schaal, T. D., & Maniatis, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.261 · Cited by 198
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
Muto, T., Sashida, G., Oshima, M., Wendt, G. R., Mochizuki‐Kashio, M., Nagata, Y., Sanada, M., Miyagi, S., Saraya, A., Kamio, A., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20131144 · Cited by 191
Brooks, A. N., Choi, P. S., de Waal, L. M., Sharifnia, T., Imielinski, M. B., Saksena, G., Pedamallu, C. S., Sivachenko, A., Rosenberg, M. W., Chmielecki, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087361 · Cited by 173
SC35 Plays a Role in T Cell Development and Alternative Splicing of CD45
Wang, H., Xu, X., Ding, J.-H., Bermingham, J. R., & Fu, X. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00181-2 · Cited by 158
Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms
Przychodzen, B. P., Jerez, A., Guinta, K. M., Sekeres, M. A., Padgett, R. A., Maciejewski, J. P., & Makishima, H. (2013) · Blood · doi:10.1182/blood-2013-01-480970 · Cited by 155
Zahler, A. M., Damgaard, C. K., Kjems, J., & Caputi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312743200 · Cited by 145
Hubert, C. G., Bradley, R. K., Ding, Y., Toledo, C. M., Herman, J., Skutt-Kakaria, K., Girard, E. J., Davison, J., Berndt, J. D., Corrin, P. D., et al. (2013) · Genes & Development · doi:10.1101/gad.212548.112 · Cited by 134
Self-citationA syn–anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well
Daubner, G. M., Cléry, A., Jayne, S., Stévenin, J., & Allain, F. H. ‐. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.367 · Cited by 133
Self-citationPeterson, R. D., Theimer, C. A., Wu, H., & Feigon, J. F. (2004) · Journal of Biomolecular NMR · doi:10.1023/b:jnmr.0000012861.95939.05 · Cited by 116
Hoen, P. A. C. ’., Hirsch, M., de Meijer, E. J., de Menezes, R. X., van Ommen, G. J., & den Dunnen, J. T. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq790 · Cited by 34
Cited by
Sorted by citations
U1 snRNP regulates cancer cell migration and invasion in vitro
Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13993-7 · Cited by 7,157
Scotti, M. M., & Swanson, M. S. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.3 · Cited by 1,163
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156
“HSCs from mice mutant for these genes, Sf3b1 (57), Srsf2 (58), and U2af1 (59), have a competitive disadvantage in vivo, unlike the clonal expansion observed in humans with these mutations.”
Goodall, G. J., & Wickramasinghe, V. O. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00306-0 · Cited by 1,090
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Robertson, A. G., Shih, J., Yau, C. S. F., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 908
Self-citation
Metadata
- Authors
- Kim, E., Ilagan, J. O., Liang, Y., Daubner, G. M., Lee, S. C.-W., Ramakrishnan, A., Li, Y., Chung, Y. R., Micol, J.-B., Murphy, M. E., Cho, H., Kim, M.-K., Zebari, A. S., Aumann, S., Park, C. Y., Buonamici, S., Smith, P. G., Deeg, H. J., Lobry, C., Aifantis, I., Modis, Y., Allain, F. H.-T., Halene, S., Bradley, R. K., & Abdel-Wahab, O.
- Affiliations
- Fred Hutch Cancer Center (US)
- Yale Cancer Center (US)
- ETH Zurich (CH)
- Memorial Sloan Kettering Cancer Center (US)
- University of Washington (US)
- Yale University (US)
- Université Paris-Sud (FR)
- Howard Hughes Medical Institute (US)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Bradley, Robert K.
- Abdel-Wahab, Omar
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 27
- Issue
- 5
- Pages
- 617-630
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4429920
- OpenAlex
- W1506037097
- Cited by
- 575
- References
- 34
- Citations by year
- 2026: 42 · 2025: 42 · 2024: 44 · 2023: 55 · 2022: 48 · 2021: 60 · 2020: 59 · 2019: 59 · 2018: 61 · 2017: 43 · 2016: 45 · 2015: 15
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (acceptedVersion, cc-by-nc-nd)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Funders
- Leukemia and Lymphoma Society
- Edward P. Evans Foundation
- Ed Evans Foundation
- National Institutes of Health
- Ellison Medical Foundation (AG-NS-1030-13, R56 DK103854)
- Damon Runyon Cancer Research Foundation (DFS 04-12)
- National Cancer Institute (P30 CA015704, P30 DK056465, T32 CA009657)
- National Institute of General Medical Sciences (101908/Z/13/Z, R01 GM102869)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK082783)
- Wellcome Trust
- U.S. Department of Defense
- Yale Cancer Center
- National Heart, Lung, and Blood Institute (U01 HL099993)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII3_127454)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- SRSF2, myelodysplastic syndrome, splicing factor mutations, exon recognition, exonic splicing enhancers, aberrant splicing, EZH2, nonsense-mediated mRNA decay, RNA binding, hematopoietic differentiation, hematopoiesis
- MeSH terms
- Serine-Arginine Splicing Factors, Enhancer of Zeste Homolog 2 Protein, Animals, Exons, Mice, Mutant Strains, Mutation, Myelodysplastic Syndromes, Nuclear Proteins, Ribonucleoproteins, RNA Splicing, Gene Expression, Mice, Proteolysis, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
